心不全における免疫線維細胞通信を標的とする
Junedh M Amrute1, Xin Luo2, Vinay Penna1
1Center for Cardiovascular Research, Division of Cardiology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO, USA.
Nature
|October 24, 2024
まとめ
炎症は特定の線維細胞集団を促すことで心臓線維症を誘発する. 免疫細胞と線維細胞におけるインタールイキン-1β (IL- 1β) 信号をターゲットにすることで,線維症が軽減され,心臓の機能が改善されました.
科学分野:
- 心血管生物学
- 免疫学
- 繊維症の研究
背景:
- 炎症と組織線維症は,臓器機能障害,特に心臓病に関連しています.
- ヒトの心臓病における免疫線維芽細胞のコミュニケーションの分子メカニズムは十分に理解されていません.
- 現在の治療法では心臓線維症を直接対象にしていません.
研究 の 目的:
- ヒトの心臓病における免疫線維細胞とのコミュニケーションの分子メカニズムを探求する.
- 心筋線維症の治療標的を特定する
主な方法:
- マルチオミック単細胞遺伝子発現,エピトープマッピング,ヒト心臓におけるクロマチンのアクセシビリティプロフィール.
- 生体内での遺伝子の追跡
- 心臓線維芽細胞モデルのマウスモデルの評価
- リガンド受容体分析と空間トランスクリプトミクス
- IL-1βシグナル伝達経路のインビボ操作
主要な成果:
- 異なったミオフィブロブラストとFAP/POSTN+マトリフィブロサイト集団と関連した線維細胞の軌道を特定した.
- FAP+ 線維細胞は POSTN 系統に寄与する.
- In vivo マウスモデルは,培養細胞よりもヒトの心臓線維症をよく再現します.
- CCR2+マクロファージとフィブロブラストの間のIL-1βシグナル伝達は,FAP/POSTN+フィブロブラストの出現を誘導する.
- 減少したFAP/ POSTN+線維細胞,心筋線維症,心機能の改善.
結論:
- インタールイウキン-1β (IL-1β) 信号伝達は,心臓線維症を誘発する免疫線維細胞の重要な媒介である.
- マクロファージとフィブロブラストのIL-1βシグナル伝達をターゲットにすることで,心臓線維症の治療戦略が提供されます.
- 炎症を軽減することで臓器の機能が保たれます
さらに関連する動画
09:16Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
Published on: June 3, 2018
7.2K
07:10Refined CLARITY-Based Tissue Clearing for Three-Dimensional Fibroblast Organization in Healthy and Injured Mouse Hearts
Published on: May 16, 2021
4.6K
関連する概念動画
01:09Introduction to Fibroblasts
3.0K
Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
3.0K
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
01:29Heart Failure II: Pathophysiology
1
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1
01:21Myocarditis I: Introduction
2
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
2
01:27Heart Failure I: Introduction
1
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1
01:30Heart Failure V: Medical Management
1
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
1